XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary shares
Class B
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 719 $ 24,281 $ (108,903) $ (83,903)
Balance (in Shares) at Dec. 31, 2022 [1] 7,187,500      
Net income (Loss) (700) (700)
Balance at Mar. 31, 2023 $ 719 24,281 (109,603) (84,603)
Balance (in Shares) at Mar. 31, 2023 [1] 7,187,500      
Balance at Dec. 31, 2022 $ 719 24,281 (108,903) (83,903)
Balance (in Shares) at Dec. 31, 2022 [1] 7,187,500      
Net income (Loss)       (1,933)
Balance at Sep. 30, 2023 $ 719 24,281 (110,836) (85,836)
Balance (in Shares) at Sep. 30, 2023 [1] 7,187,500      
Balance at Mar. 31, 2023 $ 719 24,281 (109,603) (84,603)
Balance (in Shares) at Mar. 31, 2023 [1] 7,187,500      
Net income (Loss) (617) (617)
Balance at Jun. 30, 2023 $ 719 24,281 (110,220) (85,220)
Balance (in Shares) at Jun. 30, 2023 [1] 7,187,500      
Net income (Loss) (616) (616)
Balance at Sep. 30, 2023 $ 719 24,281 (110,836) (85,836)
Balance (in Shares) at Sep. 30, 2023 [1] 7,187,500      
Balance at Dec. 31, 2023 [1] $ 719 24,281 (122,944) (97,944)
Balance (in Shares) at Dec. 31, 2023 [1] 7,187,500      
Net income (Loss) (59,738) (59,738)
Balance at Mar. 31, 2024 $ 719 24,281 (182,682) (157,682)
Balance (in Shares) at Mar. 31, 2024 7,187,500      
Balance at Dec. 31, 2023 [1] $ 719 24,281 (122,944) (97,944)
Balance (in Shares) at Dec. 31, 2023 [1] 7,187,500      
Net income (Loss)       5,367,368
Balance at Sep. 30, 2024 $ 719 (13,748,443) (13,747,724)
Balance (in Shares) at Sep. 30, 2024 7,187,500      
Balance at Mar. 31, 2024 $ 719 24,281 (182,682) (157,682)
Balance (in Shares) at Mar. 31, 2024 7,187,500      
Accretion for Class A ordinary shares to redemption amount (9,258,468) (13,244,885) (22,503,353)
Sale of 7,000,000 Private Placement Warrants 7,000,000 7,000,000
Fair value of Public Warrants at issuance 2,443,750 2,443,750
Allocated value of transaction costs (209,563) (209,563)
Accretion for Class A Ordinary shares to redemption amount   (1,948,063) (1,948,063)
Net income (Loss) 1,770,649 1,770,649
Balance at Jun. 30, 2024 $ 719 (13,604,981) (13,604,262)
Balance (in Shares) at Jun. 30, 2024 7,187,500      
Accretion for Class A ordinary shares to redemption amount       (3,799,919)
Accretion for Class A Ordinary shares to redemption amount   (3,799,919) (3,799,919)
Net income (Loss) 3,656,457 3,656,457
Balance at Sep. 30, 2024 $ 719 $ (13,748,443) $ (13,747,724)
Balance (in Shares) at Sep. 30, 2024 7,187,500      
[1] Includes an aggregate of up to 937,500 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriter’s over-allotment option is exercised (see Note 5). On February 1, 2021, the Company effected a share surrender pursuant to which 4,312,500 Class B ordinary shares were canceled, resulting in an aggregate of 7,187,500 Class B ordinary shares outstanding. On December 17, 2021, the Company effected a share capitalization with respect to Class B ordinary shares of 2,395,834 shares, resulting in the GPIAC II, LLC (the “GP sponsor”), IDS III LLC (the “Act III sponsor” and prior to March 7, 2024, together with GP sponsor, the “Co-sponsors”) and the Company’s independent directors at the time holding an aggregate of 9,583,334 Class B ordinary shares. On December 29, 2023, the Company effected a share surrender pursuant to which 2,395,834 Class B ordinary shares were canceled, resulting in an aggregate of 7,187,500 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share capitalizations (see Note 5). On May 13, 2024, as a result of the underwriter’s election to fully exercise its over-allotment option, the 937,500 shares are no longer subject to forfeiture.